Jefferies, which raised its PT on shares of Taubman Centers TCO, is providing some color on the stock.
“Our 12-month $56 PT is derived via our (DDM) and implies that one 1-year from now, TCO will trade at 18.5x and 16.5x our core '11/'12 FFO/sh est. (ex. Pier and Regency), respectively,” Jefferies writes. “The key risk is timing around the transfer of Pier and Regency.
“We are revising our 2011/2012 FFO/sh. est (including impact of Pier and Regency) to $2.74 and $3.13, respectively, from $2.74 and $3.00.”
Taubman Centers currently trades at $10.39.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in